Johnson & Johnson is a company in the U.S. stock market and it is a holding in 239 U.S.-traded ETFs. JNJ has around 181.5M shares in the U.S. ETF market. The largest ETF holder of JNJ is the SPDR S&P 500 ETF Trust (SPY), with approximately 30.08M shares. Investors may also find of interest that the ETF with the largest allocation to JNJ stock is iShares U.S. Pharmaceuticals ETF (IHE), with a portfolio weight of 20.72%. On average, U.S. ETFs allocate 1.95% of JNJ to their portfolios.
Additionally, JNJ is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with JNJ as a holding is the ProShares Ultra Health Care (RXL), with a return of 23.71%.